脑部放疗,上午比下午敏感许多!4 Q; R i. ^0 g: M% h7 P6 U
9 T# ^* g* B" A" Y/ K
1 J9 T, w# M& k# ?2 BCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
6 t) D. b7 S: q' \! q2 }6 l fGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
}/ \4 _ s) [ i. qRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.. G4 v5 Y7 D" d
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
7 Z+ M4 p! B) O2 t4 y( z) V/ z3 ~8 Z; @! I9 B7 r4 J$ q \& ?
Abstract: f8 T) _ c/ x; ~! F# U9 W7 I
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.8 D* M+ E% r- M( [# L
6 P+ X- q5 O' H5 L( E3 }% X5 @: D8 X+ ?
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.& t; [6 z6 m4 l' s
5 m) s* q+ s/ e& `
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).* y [' ]8 K% w! m$ V B2 A* o
" X) o/ R9 @8 Q+ a! A6 p
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.* ?: a l" H8 F6 c
4 s" E* b, @3 x. Z8 ?8 L |